• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ChileChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
UEGW 2024 | Latest Clinical Evidence for Biologics in EoE
Gastroenterology
11 min
expert video

UEGW 2024 | Latest Clinical Evidence for Biologics in EoE

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?
Gastroenterology
11 min
expert video

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?

UEGW 2024 | WHY Is Long-Term Management of EoE Important?
Gastroenterology
10 min
expert video

UEGW 2024 | WHY Is Long-Term Management of EoE Important?

Real-World Effectiveness of Advanced Systemic Treatments in AD
Dermatology
6 min
expert video

Real-World Effectiveness of Advanced Systemic Treatments in AD

Type 2 Inflammation in AD Manifestations in Skin and Body
Dermatology
6 min
expert video

Type 2 Inflammation in AD Manifestations in Skin and Body

Guideline-Based Diagnosis of Atopic Dermatitis
Dermatology
15 min
interactivity

Guideline-Based Diagnosis of Atopic Dermatitis

What Drives Chronic Itch and the Itch-Scratch Cycle in Atopic Dermatitis?
Dermatology
6 min
videoanimation

What Drives Chronic Itch and the Itch-Scratch Cycle in Atopic Dermatitis?

ERS 2024 | View From the Clinic: What Are the Clinical Consequences of Airway Remodeling?
Pulmonology
30 min
expert video

ERS 2024 | View From the Clinic: What Are the Clinical Consequences of Airway Remodeling?

ERS 2024 | Fireside Chat: What Is the Potential for Disease Modification in the Era of Biologics?
Pulmonology
12 min
expert video

ERS 2024 | Fireside Chat: What Is the Potential for Disease Modification in the Era of Biologics?

ERS 2024 | Can Biologics Affect Airway Remodeling?
Pulmonology
20 min
expert video

ERS 2024 | Can Biologics Affect Airway Remodeling?

ERS 2024 | What Do We Know About IL-33 Genetics?
Pulmonology
14 min
expert video

ERS 2024 | What Do We Know About IL-33 Genetics?

    1
    ...
    121314
    ...
    25